Protagenic Therapeutics

PTIX · NASDAQ

$0.75−$0.03 (−3.85%)TodayMarket closed ·
No price history for this range.

Latest news

  • Press releaseACCESS Newswire

    Protagenic Therapeutics Receives FDA Pre-IND Feedback Supporting New IND for PT00114 in Generalized Anxiety Disorder

  • Press releaseACCESS Newswire

    Protagenic Therapeutics Engages Floyd Regulatory Strategic Consulting as Regulatory Affairs Advisor and Danforth Health as Strategic Operations Partner

  • Press releaseACCESS Newswire

    Protagenic Therapeutics Appoints Industry Veteran Bill Nichols Jr. as President to Accelerate Advancement of First-in-Class TCAP Pathway Therapy PT00114

  • Press releaseACCESS Newswire

    Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • NewsHenry Khederian

    Protagenic Therapeutics (PTIX) Shares Surge On Clinical Trial Progress

  • NewsAvi Kapoor

    S&P 500 Moves Lower; Walmart Shares Fall After Q2 Results

  • NewsAvi Kapoor

    Dow Dips Over 100 Points; US Initial Jobless Claims Increase

  • News

    Protagenic Therapeutics Announces Major Restructuring: Transitions To Virtual Operating Model, Cuts $8M In Annual Costs, Halts Preclinical Programs, Terminates CEO And COO, Changes Fiscal Year-End, And Refocuses On Lead Clinical Trial For PT00114

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • Press releasePRNewswire

    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VIGL, TXNM, SVT, PTIX on Behalf of Shareholders

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • NewsAvi Kapoor

    Nasdaq Falls 100 Points; Home Depot Sales Top Views

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • Press releasePRNewswire

    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TXNM, SVT, INZY, PTIX on Behalf of Shareholders

  • NewsAvi Kapoor

    Gold Gains Over 1%; Protagenic Therapeutics Shares Spike Higher

  • News

    12 Health Care Stocks Moving In Monday's Intraday Session

  • NewsHenry Khederian

    Protagenic Therapeutics (PTIX) Stock Soars 240% On Phytanix Merger

  • Press releaseBusiness Wire

    PTIX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Protagenic Therapeutics, Inc. Is Fair to Shareholders

  • NewsAvi Kapoor

    Dow Tumbles 200 Points; ZIM Integrated Shipping Services Posts Upbeat Earnings

  • News

    12 Health Care Stocks Moving In Monday's Pre-Market Session

  • Press releaseACCESS Newswire

    Protagenic Therapeutics and Phytanix Announce Business Combination to form Neuroactive Biopharmaceutical Company with Six Drug Candidates in Development including Treatments for Obesity and Metabolic Disorders

  • Press releaseACCESS Newswire

    Protagenic Therapeutics to Effect 1-for-14 Reverse Stock Split

  • News

    12 Health Care Stocks Moving In Friday's After-Market Session

  • NewsAvi Kapoor

    Dow Tumbles 1,100 Points; US Economy Adds 228,000 Jobs In March

  • News

    11 Health Care Stocks Moving In Thursday's Intraday Session

  • NewsAvi Kapoor

    Dow Tumbles Over 1,100 Points; US Initial Jobless Claims Fall

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • NewsAvi Kapoor

    Why Penguin Solutions Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Monday's Pre-Market Session

  • NewsAvi Kapoor

    Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.